Cargando…
Concurrent Chemo- Radiobrachytherapy with Cisplatin and Medium Dose Rate Intra- Cavitary Brachytherapy for Locally Advanced Uterine Cervical Cancer
OBJECTIVE: Cervical carcinoma is the third most common gynecologic cancer, after ovarian and uterine cancers in Iran. The aim of this study was to evaluate the efficacy (response rate) and toxicity of adding Medium Dose Rate (MDR) brachytherapy with concurrent chemotherapy to External Beam Radiother...
Autores principales: | Aghili, Mahdi, Andalib, Bahram, Moghaddam, Zhaleh Karimi, Safaie, Afsaneh Maddah, Hashemi, Farnaz Amoozgar, Darzikolaie, Nima Mousavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291044/ https://www.ncbi.nlm.nih.gov/pubmed/30360600 http://dx.doi.org/10.22034/APJCP.2018.19.10.2745 |
Ejemplares similares
-
Evaluating the Incidence Rate of an Accelerated Short Course High Dose Rate Intravaginal Brachytherapy Complications in Patients with Endometrial Cancer
por: Amouzegar-Hashemi, Farnaz, et al.
Publicado: (2019) -
Initial tumor volume as an important predictor for indication of intra-cavitary brachytherapy, intra-cavitary/interstitial brachytherapy, and multi-catheter sole interstitial brachytherapy in cervical cancer patients treated with chemoradiotherapy
por: Takenaka, Tadashi, et al.
Publicado: (2023) -
Intra-cavitary brachytherapy in endometrial carcinoma: experience with cobalt-60 source
por: Rullán, Jose Antonio Domínguez, et al.
Publicado: (2022) -
Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy
por: Musso, Maria, et al.
Publicado: (2021) -
High-dose-rate intraluminal brachytherapy prior to external radiochemotherapy in locally advanced esophageal cancer: preliminary results
por: Safaei, Afsaneh Maddah, et al.
Publicado: (2017)